INSP

SEC source: 0001104659-24-039199 · tm249882-1_4seq1.xml · nonDerivative · entry 3

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,270

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.21 to $195.23. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-039199 · tm249882-1_4seq1.xml · nonDerivative · entry 2

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,770

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.225 to $194.985. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-039199 · tm249882-1_4seq1.xml · nonDerivative · entry 1

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,832

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.19 to $194.00. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-036798 · tm249390-1_4seq1.xml · derivative · entry 4

Griffin Jerry C · CIK 0001327953 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,296

Underlying: Common Stock · 1,000 shares

Expires 2028-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001104659-24-036798 · tm249390-1_4seq1.xml · nonDerivative · entry 3

Griffin Jerry C · CIK 0001327953 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,190

F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001104659-24-036798 · tm249390-1_4seq1.xml · nonDerivative · entry 2

Griffin Jerry C · CIK 0001327953 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,690

F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001104659-24-036798 · tm249390-1_4seq1.xml · nonDerivative · entry 1

Griffin Jerry C · CIK 0001327953 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-034102 · tm248803-1_4seq1.xml · derivative · entry 4

Griffin Jerry C · CIK 0001327953 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,296

Underlying: Common Stock · 1,000 shares

Expires 2028-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001104659-24-034102 · tm248803-1_4seq1.xml · nonDerivative · entry 3

Griffin Jerry C · CIK 0001327953 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,744

F3 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001104659-24-034102 · tm248803-1_4seq1.xml · nonDerivative · entry 2

Griffin Jerry C · CIK 0001327953 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,244

F2 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001104659-24-034102 · tm248803-1_4seq1.xml · nonDerivative · entry 1

Griffin Jerry C · CIK 0001327953 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,298

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The prior Form 4 for the Reporting Person dated March 5, 2024 contained a contained a computational error in the total number of securities beneficially owned following the reported transactions. The current total reflects the accurate number of shares held by the Reporting Person.

SEC source: 0001104659-24-031088 · tm248021-2_4seq1.xml · derivative · entry 4

Griffin Jerry C · CIK 0001327953 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,296

Underlying: Common Stock · 1,000 shares

Expires 2028-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001104659-24-031088 · tm248021-2_4seq1.xml · nonDerivative · entry 3

Griffin Jerry C · CIK 0001327953 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,298

F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001104659-24-031088 · tm248021-2_4seq1.xml · nonDerivative · entry 2

Griffin Jerry C · CIK 0001327953 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,798

F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001104659-24-031088 · tm248021-2_4seq1.xml · nonDerivative · entry 1

Griffin Jerry C · CIK 0001327953 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,852

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-031087 · tm248021-1_4seq1.xml · derivative · entry 3

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,555 shares

Expires 2027-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001104659-24-031087 · tm248021-1_4seq1.xml · nonDerivative · entry 1

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,822

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-030588 · tm247936-1_4.xml · nonDerivative · entry 4

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,657

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.17 to $180.14. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-030588 · tm247936-1_4.xml · nonDerivative · entry 3

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,912

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.11 to $180.01. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-030588 · tm247936-1_4.xml · nonDerivative · entry 2

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,964

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.11 to $180.01. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-030588 · tm247936-1_4.xml · nonDerivative · entry 1

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,044

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.17 to $180.25. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-028351 · tm247420-1_4seq1.xml · derivative · entry 11

Ban Randy · CIK 0001737127 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Common Stock · 3,060 shares

Expires 2028-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001104659-24-028351 · tm247420-1_4seq1.xml · nonDerivative · entry 5

Ban Randy · CIK 0001737127 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,029

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.00 to $182.25. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-028351 · tm247420-1_4seq1.xml · nonDerivative · entry 4

Ban Randy · CIK 0001737127 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,089

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-028351 · tm247420-1_4seq1.xml · derivative · entry 10

Ban Randy · CIK 0001737127 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,060

Underlying: Common Stock · 940 shares

Expires 2028-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001104659-24-028351 · tm247420-1_4seq1.xml · derivative · entry 9

Ban Randy · CIK 0001737127 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 200 shares

Expires 2027-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001104659-24-028351 · tm247420-1_4seq1.xml · derivative · entry 8

Ban Randy · CIK 0001737127 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,090 shares

Expires 2027-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001104659-24-028351 · tm247420-1_4seq1.xml · nonDerivative · entry 3

Ban Randy · CIK 0001737127 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,029

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.00 to $186.44. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-028351 · tm247420-1_4seq1.xml · nonDerivative · entry 2

Ban Randy · CIK 0001737127 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-028351 · tm247420-1_4seq1.xml · nonDerivative · entry 1

Ban Randy · CIK 0001737127 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,319

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-024892 · tm246514-1_4seq1.xml · derivative · entry 2

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,000 shares

Expires 2025-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001104659-24-024892 · tm246514-1_4seq1.xml · nonDerivative · entry 1

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-022575 · tm245999-7_4seq1.xml · derivative · entry 2

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,376

Underlying: Common Stock · 4,376 shares

Expires 2034-02-09

F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and becomeexercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC source: 0001104659-24-022575 · tm245999-7_4seq1.xml · nonDerivative · entry 1

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,262

F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents acontingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F2 · balance_after: Includes (i) 58 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2023 and (ii) 32 shares acquired under the Plan onDecember 31, 2023.

SEC source: 0001104659-24-022577 · tm245999-9_4seq1.xml · derivative · entry 2

Phillips Bryan K · CIK 0001412895 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,376

Underlying: Common Stock · 4,376 shares

Expires 2034-02-09

F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC source: 0001104659-24-022577 · tm245999-9_4seq1.xml · nonDerivative · entry 1

Phillips Bryan K · CIK 0001412895 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,571

F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC source: 0001104659-24-022576 · tm245999-8_4seq1.xml · derivative · entry 4

Ban Randy · CIK 0001737127 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,376

Underlying: Common Stock · 4,376 shares

Expires 2034-02-09

F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC source: 0001104659-24-022576 · tm245999-8_4seq1.xml · nonDerivative · entry 1

Ban Randy · CIK 0001737127 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,029

F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F2 · balance_after: Includes (i) 14 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2023 and (ii) 17 shares acquired under the Plan on December 31, 2023.

SEC source: 0001104659-24-022573 · tm245999-6_4seq1.xml · derivative · entry 2

Ebeling Philip · CIK 0001662781 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,376

Underlying: Common Stock · 4,376 shares

Expires 2034-02-09

F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC source: 0001104659-24-022573 · tm245999-6_4seq1.xml · nonDerivative · entry 1

Ebeling Philip · CIK 0001662781 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,027

F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F2 · balance_after: Includes (i) 58 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2023 and (ii) 32 shares acquired under the Plan on December 31, 2023.

SEC source: 0001104659-24-022566 · tm245999-5_4seq1.xml · derivative · entry 2

Sparks Charisse Y · CIK 0001940873 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,376

Underlying: Common Stock · 4,376 shares

Expires 2034-02-09

F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC source: 0001104659-24-022566 · tm245999-5_4seq1.xml · nonDerivative · entry 1

Sparks Charisse Y · CIK 0001940873 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,692

F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC source: 0001104659-24-022563 · tm245999-4_4seq1.xml · derivative · entry 6

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,376

Underlying: Common Stock · 4,376 shares

Expires 2034-02-09

F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC source: 0001104659-24-022563 · tm245999-4_4seq1.xml · nonDerivative · entry 1

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,271

F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F2 · balance_after: Includes (i) 58 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2023 and (ii) 32 shares acquired under the Plan on December 31, 2023.

SEC source: 0001104659-24-022562 · tm245999-3_4seq1.xml · derivative · entry 5

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,755

Underlying: Common Stock · 13,755 shares

Expires 2034-02-09

F7 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC source: 0001104659-24-022562 · tm245999-3_4seq1.xml · nonDerivative · entry 1

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,690

F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F2 · balance_after: Includes (i) 58 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2023 and (ii) 32 shares acquired under the Plan on December 31, 2023.

SEC source: 0001104659-24-022561 · tm245999-2_4seq1.xml · derivative · entry 2

Weatherby Carlton · CIK 0001986335 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,376

Underlying: Common Stock · 4,376 shares

Expires 2034-02-09

F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC source: 0001104659-24-022561 · tm245999-2_4seq1.xml · nonDerivative · entry 1

Weatherby Carlton · CIK 0001986335 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,694

F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC source: 0001104659-24-019850 · tm245999-1_4seq1.xml · derivative · entry 3

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,555

Underlying: Common Stock · 4,000 shares

Expires 2027-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

F3 · balance_after: The Reporting Person's prior Form 4 incorrectly stated the the number of options remaining following reported transactions on October 17, 2023, which has been corrected herein.

SEC source: 0001104659-24-019850 · tm245999-1_4seq1.xml · nonDerivative · entry 1

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,267

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.